Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2009.485 | The Acarbose Cardiovascular Evaluation (ACE) Trial. A Long-term, Multicentre, Double-blind, Randomised Parallel-group Trial to Determine Whether Reducing Post-prandial Glycaemia can Reduce Cardiovascular-related Morbidity and Mortality in Patients with Established Coronary Heart Disease or Acute Coronary Syndrome who have Impaired Glucose Tolerance | Prof. CHAN Juliana Chung Ngor |
| 2020.196 | Effects of dorzagliatin on 1st phase insulin and beta-cell glucose sensitivity in individuals with recent-onset type 2 diabetes and monogenic diabetes | Prof. CHAN Juliana Chung Ngor |
| 2018.457 | The mechanisms of anti-cancer effect of GLP-1 in HPV-induced diabetes/cancer model | Prof. CHAN Juliana Chung Ngor |
| 2015.636 | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 26-WEEK MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ERTUGLIFLOZIN IN ASIAN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND INADEQUATE GLYCEMIC CONTROL ON METFORMIN MONOTHERAPY |
Prof. CHAN Juliana Chung Ngor 陳重娥 |
| 2016.512 | From Genetic Discovery To Mechanisms For Prevention Of Young Onset Diabetes (YOD) (Study 1: Effects of Traditional Chinese Medicine on beta cell function and gene expression in Chinese high risk subjects harbouring genetic variants for YOD) | Prof. CHAN Juliana Chung Ngor |
| 2016.257 | Evaluation of a percutaneous optical fibre glucose sensor (Fibersense) across the glycemic range with rapid glucose excursions using the glucose clamp | Prof. CHAN Juliana Chung Ngor |
| 2020.315 | Aldose Reductase Inhibition for Stabilization of Exercise capacity in Heart Failure (ARISE-HF): A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AT-001 in Patients with Diabetic Cardiomyopathy / Stage B Heart Failure at High Risk of Progression to Overt Heart Failure (Stage C Heart Failure) |
Prof. CHAN Juliana C.N. 陳重娥 |
| 2019.601 | Effects of a novel formulation of Traditional Chinese Medicine (TCM) For Prevention of Type 2 diabetes (T2D) |
Prof. CHAN Juliana C.N. 陳重娥 |
| 2017.398 | Project Y: Using bio-genetic markers and e-coaching to promote life-long health in young to middle-aged adults with type 2 diabetes (Project Y – Diabetes) | Prof. CHAN Juliana C.N. |
| 2017.044 | Association between mTOR genetic polymorphisms, branched-chain amino acids and body mass index in Chinese patients with type 2 diabetes |
Prof. CHAN Juliana C.N. 陳重娥教授 |
| 2007.339 | Establishment of an Asia Diabetes Database (ADD) Using the Joint Asia Diabetes Evaluation (JADE) Program | Prof. CHAN Juliana C.N. |
| 2002.183 | Establishment of a Chinese-specific Catalogue of Genetic Markers for Obesity, Diabetes and Diabetic Kidney Disease | Prof. ChAN Juliana C.N. |
| 2009.421 | Identifying variants causal for Type 2 Diabetes in major human populations | Prof. CHAN Juliana C.N. |
| 2021.516 | Effects of dorzagliatin on 1st phase insulin and beta-cell glucose sensitivity in individuals with impaired and normal glucose tolerance | Prof. CHAN Juliana C.N. |
| 2022.572 | Clinical safety, efficacy and multiomic evaluation of a novel Chinese Medicine formula in Type 2 diabetes: Effects on beta-cell function and insulin resistance Substudy: Pharmacokinetic (PK) and Pharmacodynamic (PD) study of Jin Mai (JM) in healthy volunteers |
Prof. CHAN Juliana C.N. 陳重娥 |
| 2019.080 | Precision Medicine to Redefine Insulin Secretion and Monogenic Diabetes (PRISM) in Chinese Patients with Young Onset Diabetes | Dr. CHAN Juliana C.N . |
| 2009.569 | The microRNA expression profile in type 2 diabetes | Professor Chan Juliana C N |
| 2009.568 | Correlation between microRNA expression levels and histopatholohical change in type 2 diabetic patients with nephropathy | Professor Chan Juliana C N |
| 2010.281 | A Multicentre Study To Investigate The Prevalence And Factors Associated With Depression In Chinese Patients With Type 2 Diabetes | Professor Chan Juliana |
| 2010.487 | A Multipronged Approach To Discover Genomic Variants To Explain The Missing Heritability And Multifaceted Nature Of Diabetes, Cancer And Depression | Prof. CHAN Juliana |
| 2011.218 | Comparison of clinical analysis using Chinese Medicine (CM) techniques, Medical Biometrics (MB) based on pattern recognition and structured comprehensive risk assessment using JADE portal in diabetes and obesity | Professor Chan Juliana |
| 2024.153 | Clinical safety, efficacy and multiomic evaluation of a novel Chinese Medicine formula in Type 2 diabetes: Effects on beta-cell function and insulin resistance |
Dr. CHAN Juliana CHAN, Juliana Chung Ngor |
| 2009.079 | Peer Support, Empowerment And Remote Communication Linked by Information Technology (PEARL): A Multi-Component Program to Improve Community-Based Diabetes Care | Professor Chan Juliana |
| 2011.095 | JADE-JA Program: A Multi-Centre Demonstration Project to Evaluate the Effectiveness and Acceptability of the Joint Asia Diabetes Evaluation (JADE) in Chinese Type 2 Diabetic patients in Jiangsu and Anhui (JA), China | Prof. CHAN Juliana |
| 2012.199 | A Multicentre Randomized Program to Compare the Effect of the Joint Asia Diabetes Evaluation (JADE, structured care) versus the DIAbetes MONitoring Database (DIAMOND, usual care) Programs in Type 2 Diabetic Patients in Asia Pacific Region | Prof. CHAN Juliana |
| 2013.609 | A MULTICENTRE RANDOMIZED PROGRAM BY USING A DIABETIC KIDNEY DISEASE (DKD) REGISTRY TO TREAT TO MULTIPLE TARGETS (TMT) (DKD-TMT) | Prof. CHAN Juliana |
| 2010.112 | China-JD Program: A Multi-Centre Demonstration Project to Evaluate the Effectiveness and Acceptability of the Joint Asia Diabetes Evaluation (JADE) and DIAbetes MONitoring Database (DIAMOND) Programs in Chinese Type 2 Diabetic Patients | Professor Chan Juliana |
| 2020.524 | Bronchoscopic Microwave Ablation of Lung Nodules with Electromagnetic Navigation Bronchoscopy Guidance – Initial Experience with 30 Cases | Dr. CHAN Joyce Wing Yan |
| 2019.328 | Physiologic Pacing Registry |
Dr. CHAN Joseph Yat Sun 陳日新 |
| 2019.549 | ExtraVascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Study |
Dr. CHAN Joseph Yat Sun 陳日新 |
| 2019.020 | Micra Atrial TRacking Using A Ventricular AccELerometer 2 |
Dr. CHAN Joseph Yat Sun 陳日新 |
| 2019.547 | Safety and Effectiveness IDE trial for Boston Scientific’s Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation (FROzEN-AF) |
Dr. CHAN Joseph Yat Sun 陳日新醫生 |
| 2019.452 | Ventricle from Atrium Heart Failure (VFAHF) Clinical Study |
Dr. CHAN Joseph Yat Sun 陳日新 |
| 2019.019 | PREcision Event Monitoring of PatienTs with Heart Failure using HeartLogicTM (PREEMPT-HF) |
Dr CHAN Joseph Yat Sun 陳日新醫生 |
| 2020.363 | Accelerometer Sensing for Micra AV |
Dr. CHAN Joseph Yat Sun 陳日新 |
| 2004.047 | The Efficacy of Overdrive Subthreshold Pacing in Termination of Arrhythmia | Dr. CHAN Joseph Yat Sun |
| 2023.460 | Cardiac Rhythm and Heart Failure Product Surveillance Registry (PSR) Platform Base |
Dr. CHAN Joseph Yat Sun 陳日新 |
| 2021.555 | Asian Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) True Defibrillation Threshold (DFT) Study (Asian S-ICD True DFT Study) |
Dr. CHAN Joseph Yat Sun 陳日新醫生 |
| 2021.403 | Clinical Evaluation of the StablePoint Catheter and Force-Sensing System for Paroxysmal Atrial Fibrillation (NEwTON AF) |
Dr. CHAN Joseph Yat Sun 陳日新醫生 |
| 2021.515 | Conduction system pacing registry |
Dr. CHAN Joseph Yat Sun 陳日新 |
| 2021.557 | Global SYMPLICITY Registry (GSR) Denervation Findings in Real World (DEFINE) is referred to as the GSR DEFINE study. |
Dr. CHAN Joseph Yat Sun 陳日新 |
| 2023.214 | Real world Data collection in subjects treated with the FARAPULSE™ Pulsed Field Ablation system (FARADISE) |
Dr. CHAN Joseph Yat Sun 陳日新 |
| 2021.342 | Protection of Cardiac Function with Left Bundle Branch Pacing in Patients with Atrioventricular Block (OptimPacing) |
Dr. CHAN Joseph Yat Sun 陳日新 |
| 2014.453 | Acute Substernal Defibrillation (ASD) Study | Dr. CHAN Joseph Yat Sun |
| 2014.587 | Risk Estimation Following Infarction Noninvasive Evaluation - ICD efficacy Study | Dr. CHAN Joseph Yat Sun |
| 2015.525 | Expanding MRI Access for Patients with New and Existing ICDs and CRT-Ds – ENABLE MRI Study |
Dr. CHAN Joseph Yat Sun 陳日新 |
| 2014.335 | Maximizing CRT Delivery by using Multipolar Coronary Sinus Lead Family ACUITY® X4 | Dr. CHAN Joseph Yat Sun |
| 2017.402 | Attain Stability Quad Clinical Study |
Dr. CHAN Joseph Yat Sun 陳日新 |
| 2016.173 | Acute Extravascular Defibrillation, Pacing and Electrogram (ASD2) Study |
Dr. CHAN Joseph Yat Sun 陳日新 |
| 2017.319 | Prospective Clinical Registry of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) in Asian Population | Dr. CHAN Joseph Yat Sun |
Page 196 of 254.